Redsense Medical AB (REDS) — Cash Flow-to-Debt Ratio
Redsense Medical AB (REDS) has a Cash Flow-to-Debt Ratio of -0.49x as of September 2025, meaning its operating cash flow of Skr-1.92 Million could theoretically repay 0% of its total liabilities (Skr3.89 Million) in one year. See REDS free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Redsense Medical AB Cash Flow-to-Debt Ratio (2020–2024)
Historical debt coverage capacity for Redsense Medical AB across 5 annual periods. Also explore Redsense Medical AB (REDS) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Redsense Medical AB (2020–2024)
Year-by-year debt coverage analysis for Redsense Medical AB. For market capitalisation and broader financial context, see REDS market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -3.72x | Skr-8.23 Million | Skr2.21 Million | ▼ -151.1% |
| 2023 | -1.48x | Skr-5.05 Million | Skr3.41 Million | ▲ +45.8% |
| 2022 | -2.73x | Skr-9.78 Million | Skr3.58 Million | ▼ -28.7% |
| 2021 | -2.12x | Skr-12.22 Million | Skr5.76 Million | ▼ -167.8% |
| 2020 | 3.13x | Skr17.23 Million | Skr5.51 Million | — |